Francesco Galimi
- Oncology top 2%
- Molecular Biology top 10%
- Hepatology top 1%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Paolo M. ComoglioErika CottoneCarla BoccaccioAndrea BertottiEnzo MédicoLivio TrusolinoAntonia FollenziElisa Vigna
- Topics
- Colorectal Cancer Treatments and Studies (14 papers)Liver physiology and pathology (12 papers)Lung Cancer Treatments and Mutations (8 papers)
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Francesco Galimi
34 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 94
- Oncology 1.2k
- Molecular Biology 1.1k
- Hepatology 738
- Cancer Research 458
- Pulmonary and Respiratory Medicine 444
Countries citing papers authored by Francesco Galimi
This map shows the geographic impact of Francesco Galimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Galimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Galimi more than expected).
Fields of papers citing papers by Francesco Galimi
This network shows the impact of papers produced by Francesco Galimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Galimi. The network helps show where Francesco Galimi may publish in the future.
Co-authorship network of co-authors of Francesco Galimi
This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Galimi. A scholar is included among the top collaborators of Francesco Galimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Galimi. Francesco Galimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 35 | |
| 3 | 218 | |
| 4 | 25 | |
| 5 | 74 | |
| 6 | 58 | |
| 7 | 43 | |
| 8 | 147 | |
| 9 | 157 | |
| 10 | 3 | |
| 11 | 18 | |
| 12 | A RANDOMIZED, PHASE 2 STUDY OF PACLITAXEL (P) AND CARBOPLATIN (C) +/- CONATUMUMAB (CON) FOR FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) | 2 |
| 13 | 76 | |
| 14 | 108 | |
| 15 | 51 | |
| 16 | 35 | |
| 17 | 211 | |
| 18 | 18 | |
| 19 | 120 | |
| 20 | 139 |
About Francesco Galimi
Francesco Galimi is a scholar working on Hepatology, Oncology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 2.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (14 papers), Liver physiology and pathology (12 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Hepatology (738 citations), Oncology (1.2k citations) and Cancer Research (458 citations). Francesco Galimi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Paolo M. Comoglio, Erika Cottone, Carla Boccaccio, Andrea Bertotti, Enzo Médico, Livio Trusolino, Antonia Follenzi, Elisa Vigna, Giovanni Gaudino and Luigi Naldini. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.